These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9847374

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA.
    Science; 1996 Jun 28; 272(5270):1955-8. PubMed ID: 8658171
    [Abstract] [Full Text] [Related]

  • 5. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G, Tresoldi E, Björndal A, Fredriksson R, Colognesi C, Deng HK, Malnati MS, Plebani A, Siccardi AG, Littman DR, Fenyö EM, Lusso P.
    Nat Med; 1997 Nov 28; 3(11):1259-65. PubMed ID: 9359702
    [Abstract] [Full Text] [Related]

  • 6. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB, Glushakova S, Grivel JC, Murphy PM.
    J Clin Invest; 1998 May 01; 101(9):1876-80. PubMed ID: 9576751
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT.
    Lancet; 2004 Jun 19; 363(9426):2040-6. PubMed ID: 15207954
    [Abstract] [Full Text] [Related]

  • 8. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S, Menten P, Struyf S, Proost P, Van Damme J, De Clercq E, Schols D.
    J Virol; 2001 May 19; 75(9):4402-6. PubMed ID: 11287590
    [Abstract] [Full Text] [Related]

  • 9. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
    Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TN, Proudfoot AE.
    Science; 1997 Apr 11; 276(5310):276-9. PubMed ID: 9092481
    [Abstract] [Full Text] [Related]

  • 10. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y, Foda M, Matsushita S, Harada S.
    J Virol; 2000 Feb 11; 74(4):1787-93. PubMed ID: 10644351
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE.
    J Med Virol; 2004 Jun 11; 73(2):300-8. PubMed ID: 15122808
    [Abstract] [Full Text] [Related]

  • 15. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1?
    Kissler S, Süsal C, Opelz G.
    Clin Immunol Immunopathol; 1997 Sep 11; 84(3):338-41. PubMed ID: 9281393
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ, Torre VS, Johnson M, Ball SC, Cross JV, Templeton DJ, Quiñones-Mateu ME, Offord RE, Arts EJ.
    J Virol; 2001 Sep 11; 75(18):8624-38. PubMed ID: 11507208
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlöndorff D, Proudfoot AE.
    J Exp Med; 1998 Apr 20; 187(8):1215-24. PubMed ID: 9547333
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.